Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury.

Sepsis is the most common cause of acute lung injury (ALI), leading to organ dysfunction and death in critically ill patients. Previous studies associated variants of interleukin-1 receptor-associated kinase genes (IRAKs) with differential immune responses to pathogens and with outcomes during sepsis, and revealed that increased expression levels of the IRAK3 gene were correlated with poor outcomes during sepsis. Here we explored whether common variants of the IRAK3 gene were associated with susceptibility to, and outcomes of, severe sepsis. After our discovery of polymorphism, we genotyped a subset of seven single-nucleotide polymorphisms (SNPs) in 336 population-based control subjects and 214 patients with severe sepsis, collected as part of a prospective study of adults from a Spanish network of intensive care units. Whereas IRAK3 SNPs were not associated with susceptibility to severe sepsis, rs10506481 showed a significant association with the development of ALI among patients with sepsis (P = 0.007). The association remained significant after adjusting for multiple comparisons, population stratification, and clinical variables (odds ratio, 2.50; 95% confidence interval, 1.15-5.47; P = 0.021). By imputation, we revealed three additional SNPs independently associated with ALI (P < 0.01). One of these (rs1732887) predicted the disruption of a putative human-mouse conserved transcription factor binding site, and demonstrated functional effects in vitro (P = 0.017). Despite the need for replication in independent studies, our data suggest that common SNPs in the IRAK3 gene may be determinants of sepsis-induced ALI.

[1]  P. Ward Immunosuppression in sepsis. , 2011, JAMA.

[2]  Arthur S Slutsky,et al.  Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model , 2010, Intensive Care Medicine.

[3]  L. Notarangelo,et al.  Defect of regulatory T cells in patients with Omenn syndrome. , 2010, The Journal of allergy and clinical immunology.

[4]  Kai Wang Testing for genetic association in the presence of population stratification in genome‐wide association studies , 2009, Genetic epidemiology.

[5]  N. Maca-Meyer,et al.  A common haplotype of the LBP gene predisposes to severe sepsis * , 2009, Critical care medicine.

[6]  J. Granger,et al.  Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis* , 2009, Critical care medicine.

[7]  T. van der Poll,et al.  Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis) , 2009, Critical care medicine.

[8]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.

[9]  Jesús Blanco,et al.  Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study , 2008, Critical care.

[10]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[11]  J. Villar,et al.  A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury , 2008, Critical care.

[12]  T. Standiford,et al.  Immunosuppression in sepsis. , 2008, Current pharmaceutical design.

[13]  Xiaoquan Wen,et al.  Association studies for untyped markers with TUNA , 2008, Bioinform..

[14]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[15]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[16]  R. Kacmarek,et al.  A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis* , 2007, Critical care medicine.

[17]  Gonçalo R. Abecasis,et al.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.

[18]  R. Williams,et al.  Susceptibility to severe streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors , 2007, Genes and Immunity.

[19]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[20]  D. Schlessinger,et al.  IRAK-M is involved in the pathogenesis of early-onset persistent asthma. , 2007, American journal of human genetics.

[21]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[22]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[23]  I. Nolte,et al.  Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases , 2007, Scandinavian journal of gastroenterology.

[24]  S. Baudouin,et al.  A systematic review of the quality of genetic association studies in human sepsis , 2006, Intensive Care Medicine.

[25]  T. Standiford,et al.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. , 2006, The Journal of clinical investigation.

[26]  Joaquín Dopazo,et al.  PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes , 2006, Nucleic Acids Res..

[27]  E. Abraham,et al.  Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. , 2006, American journal of respiratory and critical care medicine.

[28]  N. Maca-Meyer,et al.  A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population , 2006, Genes and Immunity.

[29]  Yusuke Nakamura,et al.  An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway , 2006, Journal of Human Genetics.

[30]  M. Moss Epidemiology of sepsis: race, sex, and chronic alcohol abuse. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[32]  K. Walley,et al.  Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults* , 2005, Critical care medicine.

[33]  D. Posthuma,et al.  Heritability estimates of innate immunity: an extended twin study , 2005, Genes and Immunity.

[34]  A. Hill,et al.  Genetics of infectious diseases. , 2004, Human molecular genetics.

[35]  N. Maca-Meyer,et al.  Bench-to-bedside review: Understanding genetic predisposition to sepsis , 2004, Critical care.

[36]  C. del Fresno,et al.  Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. , 2003, Biochemical and biophysical research communications.

[37]  A. Aderem,et al.  Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.

[38]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[39]  A. Al-ghonaium,et al.  Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency , 2003, Science.

[40]  Jonathan Cohen The immunopathogenesis of sepsis , 2002, Nature.

[41]  T. Kang,et al.  A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. , 2002, Cytokine.

[42]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[43]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[44]  J. Mira,et al.  A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection , 2000, Infection and Immunity.

[45]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[46]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[49]  C. McCall,et al.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. , 1993, The Journal of clinical investigation.

[50]  Y. Chaubey Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .